CINCINNATIAn international registry of patient data established in 1968 has reached 3,000 consults from transplantation physicians and care providers across the world.
The University of Cincinnati (UC) transplant team with the Israel Penn International Transplant Tumor Registry (IPITTR) made the 3,000th consult late last week to a physician from SUNY Buffalo for a patient experiencing a post-transplant lymphoproliferative disorder.
IPITTR is the largest and most comprehensive resource of its kind in the world, providing data on transplant recipients and donors who have had or developed malignances during their treatment. The registry was founded by Israel Penn, MD, as the Denver Transplant Tumor Registry, when Penn was the first person to report on the increased incidence of malignancy following transplantation.
Through his career, Penn collected data on more than 15,000 patients for the voluntary registry and published more than 300 works on malignancy in transplantation. Following Penn's move to UC, the registry was renamed the Cincinnati Transplant Tumor Registry. In 1999, it was posthumously named the Israel Penn International Transplant Tumor Registry (IPITTR).
"The mission of the registry remains unchanged: to provide members of the transplant community with substantive data through research and publication and to provide consultative assistance in an effort to positively impact the quality of care available to organ recipients," says E. Steve Woodle, MD, director of UC's transplant division and member of the IPITTR board of directors. "The decades of consultations to the transplant community are the major reason for the breadth and depth of information in the registry."
Today, IPITTR houses data submitted by 615 transplant centers around the world, 315 of those from the United States. The data comprises a full medical picture of patients with transplant-related tumors. Using that data, along with information f
|Contact: Katy Cosse|
University of Cincinnati Academic Health Center